Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | dicarboxylate translocator | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | sodium/dicarboxylate cotransporter-related | 0.0087 | 0.5015 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0121 | 0.8471 | 1 |
Leishmania major | sodium/sulphate symporter, putative | 0.0087 | 0.5015 | 0.5 |
Echinococcus multilocularis | solute carrier family 13 | 0.0087 | 0.5015 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.5015 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.5015 | 1 |
Trichomonas vaginalis | Inorganic phosphate transporter, putative | 0.0087 | 0.5015 | 1 |
Echinococcus granulosus | solute carrier family 13 | 0.0087 | 0.5015 | 0.5 |
Echinococcus granulosus | solute carrier family 13 | 0.0087 | 0.5015 | 0.5 |
Trichomonas vaginalis | sodium-dependent high-affinity dicarboxylate transporter, putative | 0.0087 | 0.5015 | 1 |
Echinococcus granulosus | solute carrier family 13 | 0.0087 | 0.5015 | 0.5 |
Echinococcus multilocularis | solute carrier family 13 | 0.0087 | 0.5015 | 0.5 |
Echinococcus multilocularis | solute carrier family 13 | 0.0087 | 0.5015 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.5015 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.5015 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.5015 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.5015 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0121 | 0.8471 | 1 |
Trichomonas vaginalis | Inorganic phosphate transporter, putative | 0.0087 | 0.5015 | 1 |
Trypanosoma cruzi | Low-affinity phosphate transporter PHO91 | 0.0048 | 0.0991 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0121 | 0.8471 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.